The association of the PTPN22 620W polymorphism with Behçet's disease

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1531-1533

  Baranathan, Vijay ^a   Stanford, Miles R ^a   Vaughan, Robert W ^a   Kondeatis, Elli ^a   Graham, Elizabeth ^a   Fortune, Farida ^b   Madanat, Wafa ^c   Kanawati, Charlie ^d   Ghabra, Marwen ^e   Murray, Philip I ^f   Wallace, Graham R ^f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c JORDAN HOSPITAL   (Jordan)

^d St John Eye Hospital   (Israel)

^e University Hospital   (Syrian Arab Republic)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN; PROTEIN PTPN22; UNCLASSIFIED DRUG;

ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; GEL ELECTROPHORESIS; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MIDDLE EAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETINA VASCULITIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

AGED; ARABS; BEHCET SYNDROME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MIDDLE EAST; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE-PHOSPHATASE; RETINAL VASCULITIS;

EID: 35148827519     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.073866     Document Type: Article

References (15)

1. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet 2005;36:337-8.
2. Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-9.
3. Gregerson PK, Lee H-S, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Sem Immunol 2006;18:214-23.
4. Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune disease. Sem Immunol 2006;18:207-13.
5. Bonfioli AA, Orefice F. Behcet's disease. Semin Ophthalmol 2004;20:199-206.
6. Walton RC, Ashmore ED. Retinal vasculitis. Curr Opin Ophthalmol 2003;14:413-9.
7. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet's disease, the silk road and HLA-B51. Tiss Ags 1999;54:264-72.
8. Chen Y, Vaughan RW, Kondeatis E, Edelsten CE, Graham EM, Stanford MR, et al. Are cytokine gene polymorphisms associated with outcome in patients with retinal vasculitis. Br J Ophthalmol 2005;89:1013-6.
9. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078.
10. Chapman SJ, Khor C, Vannberg FO, Maskell NA, Davies CWH, Hedley EL, et al. PTPN22 and invasive bacterial disease. Nat Genet 2006;38:499-500.
11. Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K, et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22). Am J Med Genet A 2006;140:586-93.
12. Gomez LM, Anaya J-M, Martin J. Genetic influence of PTPN22 R620W polymorphism in tuberculosis. Hum Immunol 2005;66:1242-7.
13. Lakshmi VV, Rakh SS, Radhu BA, Priya VHS, Pantula V, Jasti S, et al. Role of HLA-B51 and HLA-B52 in susceptibility to tuberculosis. Infect Gen Evol 2006;6:436-9.
14. Pervin K, Childerstone A, Shinnick T, Mizushima Y, van der Zee R, Hasan A, et al. T cell epitope expression of mycobacterial and homologous human 65 kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease. J Immunol 1993;151:2273-82.
15. Gul, A. Behcet's disease as an autoinflammatory disorder Curr Drug Targets Inflamm Allergy 2005;4:81-3.